← All Matinas Biopharma Holdings, INC filings

Matinas Biopharma Holdings, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
MTNB
Matinas Biopharma Holdings, INC
DEF: Matinas BioPharma Holdings Proposes Reverse Stock Split, Increases Authorized Shares, and New Equity Incentive Plan
Matinas BioPharma Holdings seeks stockholder approval for a reverse stock split, an increase in authorized shares, and a new equity incentive plan at its upcoming annual meeting.
AMEX
MTNB
Matinas Biopharma Holdings, INC
DEF: Matinas BioPharma Seeks Stockholder Approval for Key Stock Issuance and Change of Control
Matinas BioPharma is holding a special meeting on April 4, 2025, to seek stockholder approval for a stock issuance that could result in a change of control, as well as to ratify the appointment of its independent auditor.